Quest Diagnostics Incorporated Share Price

Equities

DGX

US74834L1008

Healthcare Facilities & Services

Market Closed - Nyse 01:30:02 05/06/2024 am IST 5-day change 1st Jan Change
141.6 USD +0.33% Intraday chart for Quest Diagnostics Incorporated +1.91% +2.68%
Sales 2024 * 944.67Cr 79TCr Sales 2025 * 976.48Cr 81TCr Capitalization 1.57TCr 1,31100Cr
Net income 2024 * 90Cr 7.48TCr Net income 2025 * 97Cr 8.1TCr EV / Sales 2024 * 2.09 x
Net Debt 2024 * 403.54Cr 34TCr Net Debt 2025 * 355.65Cr 30TCr EV / Sales 2025 * 1.97 x
P/E ratio 2024 *
18.1 x
P/E ratio 2025 *
16.6 x
Employees 44,000
Yield 2024 *
2.08%
Yield 2025 *
2.1%
Free-Float 68.24%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.33%
1 week+1.91%
Current month-0.28%
1 month+3.05%
3 months+12.98%
6 months+2.97%
Current year+2.68%
More quotes
1 week
137.36
Extreme 137.36
142.25
1 month
135.35
Extreme 135.35
145.62
Current year
123.04
Extreme 123.04
145.62
1 year
119.59
Extreme 119.59
145.62
3 years
119.59
Extreme 119.59
174.16
5 years
73.02
Extreme 73.02
174.16
10 years
56.27
Extreme 56.27
174.16
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 01/13/01
Director of Finance/CFO 54 11/22/11
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 70 18/19/18
Director/Board Member 66 07/11/07
Director/Board Member 74 01/04/01
More insiders
Date Price Change Volume
04/24/04 141.6 +0.33% 818,752
03/24/03 141.1 -0.61% 634,334
31/24/31 142 +1.89% 2,238,021
30/24/30 139.3 +0.82% 838,572
29/24/29 138.2 -0.52% 986,770

Delayed Quote Nyse, June 05, 2024 at 01:30 am IST

More quotes
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (2.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
141.6 USD
Average target price
147 USD
Spread / Average Target
+3.84%
Consensus